M. Moosa et El. Mazzaferri, OUTCOME OF DIFFERENTIATED THYROID-CANCER DIAGNOSED IN PREGNANT-WOMEN, The Journal of clinical endocrinology and metabolism, 82(9), 1997, pp. 2862-2866
The clinical features and outcome of thyroid cancer in 61 pregnant wom
en (mean age, 26.0 +/- 5.9 sn yr) and in 528 female, age-matched contr
ols who were not pregnant (mean age, 26.3 +/- 5.9 so yr) were compared
. Median follow-up was 22.4 and 19.5 yr [P = not significant (NS)] in
the two groups, respectively. The thyroid nodule was asymptomatic and
discovered on routine examination more often in the pregnant women (74
%) than in controls (43%, P < 0.001); other clinical and tumor feature
s were similar in the two groups. Most of the pregnant women underwent
thyroidectomy after delivery (77%) or during the second trimester of
pregnancy (20%). Near-total thyroidectomy was done in 43 (73%) of the
pregnant women and 265 (59%) of the controls (P = NS), and nearly the
same proportion of both groups (30% and 25%, respectively) were treate
d with I-131 postoperatively. Outcome in the pregnant women and contro
ls, respectively, was: cancer recurrence 9 (15%) and 107 (23%, P = NS)
; distant recurrences 1 (2%) and 12 (3%,P = NS), and cancer deaths 0 a
nd 6 (1.2%, P = NS). Outcomes were similar when surgery was done durin
g or after pregnancy, despite a longer delay in treatment of the latte
r (1.1 +/- 1.0 us. 16.1 +/- 19.7 months, P < 0.001). This study sugges
ts that the prognosis of differentiated thyroid cancer is the same in
pregnant women and nonpregnant women of the same age, and that the dia
gnosis and treatment of thyroid cancer occurring during pregnancy can
be delayed until after delivery in most patients.